Sarah Proehl

Appearances

EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS IN THE ASSURE STUDY: INTERIM RESULTS
Date
May 18, 2024
BACKGROUND: Seladelpar, a potent and selective PPAR-delta agonist, has anti-cholestatic and anti-pruritic activity in patients with primary biliary cholangitis (PBC)…
Presenter
Cynthia Levy
University of Miami
Speakers
Stuart Gordon
Eric Lawitz
Kidist Yimam
Gautham Reddy
Adam Peyton
Shuqiong Zhuo
Sarah Proehl
Carrie Heusner
Daria Crittenden
Charles Mcwherter